SCHEMBL7095984

SCHEMBL7095984

CCOC(=O)c1ccc(NC(CC)c2nc(=O)c3cccnc3s2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.68
RAB9A P51151 5/20 0.68
SMN1; SMN2 Q16637 4/20 0.68
MAPT P10636 4/20 0.68
CYP1A2 P05177 1/20 0.68
CYP2C9 P11712 1/20 0.68
HPGD P15428 1/20 0.68
CYP2C19 P33261 1/20 0.68
RXFP1 Q9HBX9 2/20 0.49
LMNA P02545 4/20 0.45
TSHR P16473 1/20 0.45
KDM4E B2RXH2 1/20 0.44
POLB P06746 1/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPK1 P28482 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
KMT2A Q03164 1/20 0.43
RGS12 O14924 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7096578 0.81 RAB9A (1.00) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL7096050 0.74 NPC1 (0.63) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL7095985 0.72 KMT2A (0.76) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL7099828 0.70 ALDH1A1 (0.64) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL7096970 0.67 MAPT (0.52) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL7096971 0.67 MAPT (0.52) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL8117431 0.66 RAB9A (0.61) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL9911362 0.66 RAB9A (0.60) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL719584 0.66 KDM4E (0.58) NPC1RAB9ASMN1; SMN2MAPTCYP1A2
SCHEMBL11257194 0.66 RAB9A (0.53) NPC1RAB9ASMN1; SMN2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0878196-B1 KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES YAMANOUCHI PHARMA CO LTD (JP) 2003-09-03 EP disclosed
US-6133258-A PYRIDOTHIAZINE DERIVATIVE; FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, MULTIPLE SCLEROSIS, PAIN, GLAUCOMA YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2000-10-17 US disclosed
EP-0878196-A1 KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1998-11-18 EP disclosed